Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus

被引:290
作者
Rozzo, SJ
Allard, JD
Choubey, D
Vyse, TJ
Izui, S
Peltz, G
Kotzin, BL [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80262 USA
[3] Roche Biosci, Palo Alto, CA 94304 USA
[4] Loyola Univ, Stritch Sch Med, Dept Radiat Oncol, Maywood, IL 60153 USA
[5] Ctr Med Univ Geneva, Dept Pathol, CH-1211 Geneva 4, Switzerland
[6] Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA
关键词
D O I
10.1016/S1074-7613(01)00196-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Nba2 locus is a major genetic contribution to disease susceptibility in the (NZB X NZW)F-1 mouse model of systemic lupus. We generated C57BL/6 mice congenic for this NZB locus, and these mice produced antinuclear autoantibodies characteristic of lupus. F-1 offspring of congenic and NZW mice developed high autoantibody levels and severe lupus nephritis similar to (NZB X NZW)F1 mice. Expression profiling with oligonucleotide microarrays revealed only two differentially expressed genes, interferon-inducible genes Ifi202 and Ifi203, in congenic versus control mice, and both were within the Nba2 interval. Quantitative PCR localized increased Ifi202 expression to splenic B cells and non-T/non-B cells. These results, together with analyses of promoter region polymorphisms, strain distribution of expression, and effects on cell proliferation and apoptosis, implicate Ifi202 as a candidate gene for lupus.
引用
收藏
页码:435 / 443
页数:9
相关论文
共 42 条
[11]  
Germer S, 1999, GENOME RES, V9, P72
[12]   SELF-TOLERANCE CHECKPOINTS IN B-LYMPHOCYTE DEVELOPMENT [J].
GOODNOW, CC ;
CYSTER, JG ;
HARTLEY, SB ;
BELL, SE ;
COOKE, MP ;
HEALY, JI ;
AKKARAJU, S ;
RATHMELL, JC ;
POGUE, SL ;
SHOKAT, KP .
ADVANCES IN IMMUNOLOGY, VOL 59, 1995, 59 :279-368
[13]   In vitro and in vivo expression analysis of the interferon-inducible 203 gene [J].
Gribaudo, G ;
Riera, L ;
Hertel, L ;
Landolfo, S .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (02) :129-136
[14]  
GRIBAUDO G, 1987, J BIOL CHEM, V262, P11878
[15]  
Gutterman JU, 1999, CELL GROWTH DIFFER, V10, P93
[16]   The genetics of human systemic lupus erythematosus [J].
Harley, JB ;
Moser, KL ;
Gaffney, PM ;
Behrens, TW .
CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (06) :690-696
[17]  
Johnstone RW, 1999, MOL CELL BIOL, V19, P5833
[18]   Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma [J].
Karp, CL ;
Grupe, A ;
Schadt, E ;
Ewart, SL ;
Keane-Moore, M ;
Cuomo, PJ ;
Köhl, J ;
Wahl, L ;
Kuperman, D ;
Germer, S ;
Aud, D ;
Peltz, G ;
Wills-Karp, M .
NATURE IMMUNOLOGY, 2000, 1 (03) :221-226
[19]   LUPUS SUSCEPTIBILITY LOCI IN NEW-ZEALAND MICE [J].
KONO, DH ;
BURLINGAME, RW ;
OWENS, DG ;
KURAMOCHI, A ;
BALDERAS, RS ;
BALOMENOS, D ;
THEOFILOPOULOS, AN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (21) :10168-10172
[20]   Systemic lupus erythematosus [J].
Kotzin, BL .
CELL, 1996, 85 (03) :303-306